Pipex Reports Positive Results From Dry AMD Study | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Friday, July 11, 2008

Email

Comments

TradingMarkets.com

Pipex Pharmaceuticals has announced positive results from a double-blind, placebo-controlled clinical trial for the treatment of dry age-related macular degeneration with oral Zinthionein.

Retina Products and Equipment »

All of the following are true of primary Sjogren Syndrome except:
1. Most commonly found in elderly males
2. No associated connective tissue disease
3. 90% HLA-B8 haplotype +
4. Associated with anti-La (SS-B) autoantibodies
Check The Answer

3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us